Clinical Trial Update: 4% Articaine and 2% Lidocaine by Intraligamentary Technique in Irreversible Pulpitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intraligamentary administration of 4% articaine and 2% lidocaine for irreversible pulpitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irreversible Pulpitis

Drugs mentioned

• Articaine (4%) (articaine)
• Lidocaine 2% (Lidocaine)

Snippet

Sponsor: Dr. D. Y. Patil Dental College & Hospital | Conditions: Irreversible Pulpitis | Phase 3 | Status: COMPLETED